Annick Causse

MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy

Salomé Paillas, Annick Causse, Laetitia Marzi et al. · Autophagy · 2012 · 95 citations · Full text

Apoptosis, Immunology, Cell Death +20

Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

Salomé Paillas, Florence Boissière‐Michot, Frédéric Bibeau et al. · Cancer Research · 2010 · 84 citations · Full text

Cancer Biology, Tumor Biology, Molecular Pharmacology +18

New Topoisomerase I mutations are associated with resistance to camptothecin

Céline Gongora, Nadia Vezzio-Vié, Sandie Tuduri et al. · Molecular Cancer · 2011 · 75 citations · Full text

Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump

Thibault Mazard, Annick Causse, J Simony et al. · Molecular Cancer Therapeutics · 2013 · 54 citations · Full text

At least five regions of imbalance on 6q in breast tumors, combining losses and gains

Carmen Rodríguez, Annick Causse, Elisabeth Ursule et al. · Genes Chromosomes and Cancer · 2000 · 52 citations

Breast Oncology, Cytogenetics, Genetics +18